Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 11 » Issue 1

COPD exacerbation care bundle improves standard of care, length of stay, and readmission rates

Authors Parikh R, Shah T, Tandon R

Received 12 November 2015

Accepted for publication 13 January 2016

Published 17 March 2016 Volume 2016:11(1) Pages 577—583

DOI https://doi.org/10.2147/COPD.S100401

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Dr Richard Russell

Raj Parikh,1 Trushil G Shah,2 Rajive Tandon2

1Department of Internal Medicine, 2Department of Pulmonary and Critical Care Medicine, Rush University Medical Center, Chicago, IL, USA

Introduction:
COPD is the third leading cause of death in the world. Utilizing care bundles during acute COPD exacerbations results in fewer complications and lower costs. Our aim was to construct a COPD exacerbation care bundle and evaluate the effects on patient care.
Methods: We conducted a prospective analysis of 44 patients admitted with a COPD exacerbation to a single tertiary care facility. Primary outcomes included length of stay, readmission rates, and hospital costs. Secondary outcomes included patient education, pulmonologist follow-up, and timeliness of medication administration. Two cohorts were analyzed: those treated with an electronic COPD care bundle (cases; N=22) versus those treated without the care bundle (controls; N=22).
Results: Mean length of stay (51.2 vs 101.1 hours in controls; P-value =0.001), 30-day readmission rates (9.1% vs 54.4% in controls; P-value =0.001), and 60-day readmission rates (22.7% vs 77% in controls; P-value =0.0003) decreased in the care bundle group. Ninety-day hospital costs had a significant difference in the care bundle group (US$7,652 vs US$19,954 in controls; P-value =0.044). Secondary outcomes included a 100% rate of COPD inhaler teaching (vs 27.3% in controls; P-value <0.001), 59.1% rate of pulmonologist follow-up after discharge (vs 18.2% in controls; P-value =0.005), and a mean reduction in time to steroid administration (7.0 hours; P-value =0.015) seen in the care bundle cases.
Conclusion: Our significant findings coupled with the recent success of standardized algorithms in managing COPD exacerbations stress the importance of enforcing clinical guidelines that can enhance patient care. We demonstrated improved care for COPD exacerbation patients during hospitalizations, thereby decreasing morbidity and the financial burden hospitals face in regard to this increasingly prevalent disease.

Keywords:
acute exacerbation of chronic obstructive lung disease, COPD, care bundle

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

COPD phenotypes on computed tomography and its correlation with selected lung function variables in severe patients

da Silva SMD, Paschoal IA, De Capitani EM, Moreira MM, Palhares LC, Pereira MC

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:503-513

Published Date: 16 March 2016

Cognitive status among patients with chronic obstructive pulmonary disease

Roncero C, Campuzano AI, Quintano JA, Molina J, Pérez J, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:543-551

Published Date: 16 March 2016

Microparticles in sputum of COPD patients: a potential biomarker of the disease?

Lacedonia D, Carpagnano GE, Trotta T, Palladino GP, Panaro MA, Zoppo LD, Foschino Barbaro MP, Porro C

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:527-533

Published Date: 14 March 2016

Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation

Santos S, Marin A, Serra-Batlles J, de la Rosa D, Solanes I, Pomares X, López-Sánchez M, Muñoz-Esquerre M, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:515-525

Published Date: 11 March 2016